Girolamo Todd C 4
4 · CALADRIUS BIOSCIENCES, INC. · Filed Jan 12, 2022
Insider Transaction Report
Form 4
Girolamo Todd C
CLO, SVP of Corp Dev
Transactions
- Award
Common Stock
2022-01-10+129,000→ 187,675 total - Tax Payment
Common Stock
2022-01-10$0.92/sh−17,405$15,960→ 170,270 total - Tax Payment
Common Stock
2022-01-11$0.87/sh−4,722$4,085→ 165,548 total - Award
Stock Option (Right to Buy)
2022-01-10+65,000→ 65,000 totalExercise: $0.92From: 2022-01-10Exp: 2032-01-10→ Common Stock (65,000 underlying)
Footnotes (5)
- [F1]Represents 129,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
- [F2]Includes 136,500 unvested restricted stock.
- [F3]Shares withheld as payment of a tax liability on vesting of restricted stock.
- [F4]Includes 127,750 unvested restricted stock.
- [F5]One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.